Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA.
BMJ. 2011 May 5;342:d2431. doi: 10.1136/bmj.d2431.
To evaluate the association between arsenic exposure and mortality from cardiovascular disease and to assess whether cigarette smoking influences the association.
Prospective cohort study with arsenic exposure measured in drinking water from wells and urine.
General population in Araihazar, Bangladesh.
11,746 men and women who provided urine samples in 2000 and were followed up for an average of 6.6 years.
Death from cardiovascular disease.
198 people died from diseases of circulatory system, accounting for 43% of total mortality in the population. The mortality rate for cardiovascular disease was 214.3 per 100,000 person years in people drinking water containing <12.0 µg/L arsenic, compared with 271.1 per 100,000 person years in people drinking water with ≥ 12.0 µg/L arsenic. There was a dose-response relation between exposure to arsenic in well water assessed at baseline and mortality from ischaemic heart disease and other heart disease; the hazard ratios in increasing quarters of arsenic concentration in well water (0.1-12.0, 12.1-62.0, 62.1-148.0, and 148.1-864.0 µg/L) were 1.00 (reference), 1.22 (0.65 to 2.32), 1.35 (0.71 to 2.57), and 1.92 (1.07 to 3.43) (P = 0.0019 for trend), respectively, after adjustment for potential confounders including age, sex, smoking status, educational attainment, body mass index (BMI), and changes in urinary arsenic concentration since baseline. Similar associations were observed when baseline total urinary arsenic was used as the exposure variable and for mortality from ischaemic heart disease specifically. The data indicate a significant synergistic interaction between arsenic exposure and cigarette smoking in mortality from ischaemic heart disease and other heart disease. In particular, the hazard ratio for the joint effect of a moderate level of arsenic exposure (middle third of well arsenic concentration 25.3-114.0 µg/L, mean 63.5 µg/L) and cigarette smoking on mortality from heart disease was greater than the sum of the hazard ratios associated with their individual effect (relative excess risk for interaction 1.56, 0.05 to 3.14; P = 0.010).
Exposure to arsenic in drinking water is adversely associated with mortality from heart disease, especially among smokers.
评估砷暴露与心血管疾病死亡率之间的关联,并评估吸烟是否会影响这种关联。
前瞻性队列研究,砷暴露通过水井和尿液中的测量进行评估。
孟加拉国阿里哈扎尔的普通人群。
2000 年提供尿液样本并平均随访 6.6 年的 11746 名男性和女性。
心血管疾病死亡。
198 人死于循环系统疾病,占该人群总死亡率的 43%。饮用水中砷含量<12.0μg/L 的人群心血管疾病死亡率为 214.3/10 万人口年,而饮用水中砷含量≥12.0μg/L 的人群为 271.1/10 万人口年。基线时评估的井水砷暴露与缺血性心脏病和其他心脏病死亡率之间存在剂量-反应关系;井水砷浓度(0.1-12.0、12.1-62.0、62.1-148.0 和 148.1-864.0μg/L)增加的四个季度的危险比分别为 1.00(参考)、1.22(0.65 至 2.32)、1.35(0.71 至 2.57)和 1.92(1.07 至 3.43)(P=0.0019 趋势),在调整了年龄、性别、吸烟状况、教育程度、体重指数(BMI)和基线后尿液砷浓度变化等潜在混杂因素后。当使用基线总尿砷作为暴露变量时,以及当缺血性心脏病死亡率作为特定观察指标时,观察到了类似的关联。数据表明,砷暴露与吸烟之间在缺血性心脏病和其他心脏病的死亡率方面存在显著协同交互作用。特别是,中度砷暴露(井水砷浓度中位数为 25.3-114.0μg/L,平均值为 63.5μg/L)与吸烟对心脏病死亡率的联合效应的危险比大于其各自效应相关的危险比之和(交互作用的相对超额风险为 1.56,0.05 至 3.14;P=0.010)。
饮用水中砷的暴露与心脏病死亡率呈负相关,尤其是在吸烟者中。